Lip cancer, a subtype of oral cancer, poses a significant health concern globally. Research in this field delves into various aspects, including risk factors, early detection methods, and treatment modalities. Studies highlight the role of tobacco and alcohol consumption as primary risk factors, emphasizing the importance of lifestyle modifications for prevention. Furthermore, advancements in molecular biology have led to the identification of genetic markers associated with lip cancer, aiding in personalized treatment approaches. Early detection techniques such as screening programs and innovative imaging technologies offer promising avenues for timely intervention. Additionally, ongoing research explores novel therapeutic strategies, including targeted drug therapies and immunotherapies, to improve patient outcomes. Collaborative efforts among researchers, healthcare professionals, and policymakers are crucial in advancing lip cancer research and addressing the growing burden of this disease.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States